Showing results (251-260 of 295) with videos related to
Sort By:
Pageof 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2026
Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603Yukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa, et al.Annals of Surgery|August 8, 2023
Prognostic Relevance of Primary Tumor Sidedness in Early-stage Colorectal Cancer: An Integrated Analysis of 4 Randomized Controlled Trials (JCOG2003A)Akira Ouchi, Ryo Sadachi, Tetsuya Hamaguchi, et al.Molecular and Clinical Oncology|January 13, 2021
Relationship between cervical esophageal squamous cell carcinoma and human papilloma virus infection and gene mutationsMasaru Fukahori, Ken Kato, Hirokazu Taniguchi, et al.European Journal of Cancer (Oxford, England : 1990)|April 21, 2018
A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trialChu Matsuda, Megumi Ishiguro, Satoshi Teramukai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2021
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical TrialYukihide Kanemitsu, Kohei Shitara, Junki Mizusawa, et al.Journal of Human Genetics|September 11, 2007
Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differencesKeiko Maekawa, Mayumi Saeki, Yoshiro Saito, et al.The Lancet. Oncology|August 17, 2010
Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)Kei Muro, Narikazu Boku, Yasuhiro Shimada, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 8, 2025
Risk of peritoneal recurrence following laparoscopic versus open surgery for stage II/III colorectal cancer: An integrated analysis of three Phase III randomized controlled trials (JCOG2310AS2)Marie Hanaoka, Kozo Kataoka, Junki Mizusawa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2024
Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)Atsuo Takashima, Tetsuya Hamaguchi, Junki Mizusawa, et al.European Journal of Cancer (Oxford, England : 1990)|November 23, 2024
Sex differences in toxicities and survival outcomes among Japanese patients with Stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of 4 randomized controlled trials (JCOG2310A)Hidekazu Hirano, Kozo Kataoka, Toshifumi Yamaguchi, et al.Pageof 30